Cel Sci Corporation (CVM)

[Biobonic]

Very little about Cel Sci has been 'on time'

Phase 3 delayed at the start, in the midst, at the endpoint, at the data lock.

Why would the Full Data be any different?

One aspect of Full Data: This bulk of individuals' data, investigators notes, etc. will be what Geert shops to the BP, and uses for the BLA.

If one were to consider forking over $Billions wouldn't one want their Chief Investigative Drug team to go over the clinical data, as assembled in the full data documents with a fine tooth comb.

No need to hurry the statistical full data compilation process, what's a few weeks if it means getting the data in the best presentable format that conveys the benefit of Multikine.

Anyone have an idea of how many pages a typical BLA or NDA contain?